annual total liabilities:
$436.69M+$378.01M(+644.14%)Summary
- As of today (September 16, 2025), SNDX annual total liabilities is $436.69 million, with the most recent change of +$378.01 million (+644.14%) on December 31, 2024.
- During the last 3 years, SNDX annual total liabilities has risen by +$395.40 million (+957.65%).
- SNDX annual total liabilities is now at all-time high.
Performance
SNDX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$438.73M+$13.08M(+3.07%)Summary
- As of today (September 16, 2025), SNDX quarterly total liabilities is $438.73 million, with the most recent change of +$13.08 million (+3.07%) on June 30, 2025.
- Over the past year, SNDX quarterly total liabilities has increased by +$396.12 million (+929.65%).
- SNDX quarterly total liabilities is now at all-time high.
Performance
SNDX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SNDX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +644.1% | +929.6% |
| 3 y3 years | +957.6% | +886.0% |
| 5 y5 years | +1267.9% | +875.4% |
SNDX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1366.0% | at high | +1932.5% |
| 5 y | 5-year | at high | +1366.0% | at high | +1932.5% |
| alltime | all time | at high | +8278.6% | at high | +9335.0% |
SNDX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $438.73M(+3.1%) |
| Mar 2025 | - | $425.65M(-2.5%) |
| Dec 2024 | $436.69M(+644.1%) | $436.69M(+635.4%) |
| Sep 2024 | - | $59.38M(+39.4%) |
| Jun 2024 | - | $42.61M(-16.7%) |
| Mar 2024 | - | $51.14M(-12.9%) |
| Dec 2023 | $58.68M(+97.0%) | $58.68M(+46.6%) |
| Sep 2023 | - | $40.04M(+27.9%) |
| Jun 2023 | - | $31.30M(+28.7%) |
| Mar 2023 | - | $24.32M(-18.4%) |
| Dec 2022 | $29.79M(-27.9%) | $29.79M(+38.0%) |
| Sep 2022 | - | $21.59M(-51.5%) |
| Jun 2022 | - | $44.50M(-6.7%) |
| Mar 2022 | - | $47.67M(+15.5%) |
| Dec 2021 | $41.29M(-14.7%) | $41.29M(+2.0%) |
| Sep 2021 | - | $40.50M(-16.5%) |
| Jun 2021 | - | $48.50M(-5.8%) |
| Mar 2021 | - | $51.47M(+6.3%) |
| Dec 2020 | $48.42M(+51.7%) | $48.42M(+2.3%) |
| Sep 2020 | - | $47.33M(+5.2%) |
| Jun 2020 | - | $44.98M(-12.9%) |
| Mar 2020 | - | $51.65M(+61.8%) |
| Dec 2019 | $31.93M | $31.93M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $32.34M(+0.7%) |
| Jun 2019 | - | $32.12M(+4.4%) |
| Mar 2019 | - | $30.77M(-0.4%) |
| Dec 2018 | $30.89M(-6.0%) | $30.89M(-4.0%) |
| Sep 2018 | - | $32.19M(-8.1%) |
| Jun 2018 | - | $35.02M(+6.1%) |
| Mar 2018 | - | $33.01M(+0.4%) |
| Dec 2017 | $32.87M(+32.1%) | $32.87M(+18.3%) |
| Sep 2017 | - | $27.78M(+9.7%) |
| Jun 2017 | - | $25.33M(+1.1%) |
| Mar 2017 | - | $25.05M(+0.7%) |
| Dec 2016 | $24.87M(+7.2%) | $24.87M(+4.1%) |
| Sep 2016 | - | $23.89M(+10.5%) |
| Jun 2016 | - | $21.61M(-3.6%) |
| Mar 2016 | - | $22.41M(+50.4%) |
| Dec 2015 | $23.20M(+25.2%) | - |
| Dec 2014 | $18.53M(+255.6%) | - |
| Sep 2014 | - | $14.90M(+178.6%) |
| Jun 2014 | - | $5.35M(+15.1%) |
| Mar 2014 | - | $4.65M(-10.8%) |
| Dec 2013 | $5.21M(-83.1%) | $5.21M(-47.1%) |
| Sep 2013 | - | $9.85M |
| Dec 2012 | $30.80M(+29.2%) | - |
| Dec 2011 | $23.84M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of SNDX is $436.69M
What is the all time high annual total liabilities for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual total liabilities is $436.69M
What is Syndax Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, SNDX annual total liabilities has changed by +$378.01M (+644.14%)
What is Syndax Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of SNDX is $438.73M
What is the all time high quarterly total liabilities for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly total liabilities is $438.73M
What is Syndax Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, SNDX quarterly total liabilities has changed by +$396.12M (+929.65%)